MLKL Inhibits Intestinal Tumorigenesis by Suppressing STAT3 Signaling Pathway
Overview
Authors
Affiliations
Mixed lineage kinase domain-like protein (MLKL) plays an important role in necroptosis, but the role and mechanism of MLKL in intestinal tumorigenesis remain unclear. Here, we found that hematopoietic- and nonhematopoietic-derived MLKL affected intestinal inflammation, but nonhematopoietic-derived MLKL primarily inhibited intestinal tumorigenesis. Loss of MLKL enhanced intestinal regeneration and the susceptibility to intestinal tumorigenesis in mice by hyperactivating the Janus kinase 2 (JAK2)/ signal transducer and activator of transcription 3 (STAT3) axis. Furthermore, MLKL deficiency increased interleukin-6 (IL-6) production in dendritic cells. Administration of anti-IL-6R antibody therapy reduced intestinal tumorigenesis in mice. Notably, low MLKL expression in human colorectal tumors, which enhanced STAT3 activation, was associated with decreased overall survival. Together, our results reveal that MLKL exhibits a suppressive effect during intestinal tumorigenesis by suppressing the IL-6/JAK2/STAT3 signals.
MLKL promotes hepatocarcinogenesis through inhibition of AMPK-mediated autophagy.
Yu X, Feng M, Guo J, Wang H, Yu J, Zhang A Cell Death Differ. 2024; 31(8):1085-1098.
PMID: 38783090 PMC: 11303813. DOI: 10.1038/s41418-024-01314-5.
Emmerich K, Walker S, Wang G, White D, Ceisel A, Wang F PLoS Genet. 2023; 19(10):e1010905.
PMID: 37819938 PMC: 10593236. DOI: 10.1371/journal.pgen.1010905.
The Many Faces of MLKL, the Executor of Necroptosis.
Martinez-Osorio V, Abdelwahab Y, Ros U Int J Mol Sci. 2023; 24(12).
PMID: 37373257 PMC: 10298923. DOI: 10.3390/ijms241210108.
Zhou P, Zhang S, Wang M, Zhou J Biomolecules. 2023; 13(5).
PMID: 37238692 PMC: 10216135. DOI: 10.3390/biom13050820.
MLKL signaling regulates macrophage polarization in acute pancreatitis through CXCL10.
Peng C, Tu G, Wang J, Wang Y, Wu P, Yu L Cell Death Dis. 2023; 14(2):155.
PMID: 36828808 PMC: 9958014. DOI: 10.1038/s41419-023-05655-w.